156 related articles for article (PubMed ID: 32515721)
1. Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence.
Jones HJ; Hammerton G; McCloud T; Hines LA; Wright C; Gage SH; Holmans P; Jones PB; Davey Smith G; Linden DEJ; O'Donovan MC; Owen MJ; Walters JT; Munafò MR; Heron J; Zammit S
Psychol Med; 2022 Jan; 52(1):132-139. PubMed ID: 32515721
[TBL] [Abstract][Full Text] [Related]
2. Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence.
French L; Gray C; Leonard G; Perron M; Pike GB; Richer L; Séguin JR; Veillette S; Evans CJ; Artiges E; Banaschewski T; Bokde AW; Bromberg U; Bruehl R; Buchel C; Cattrell A; Conrod PJ; Flor H; Frouin V; Gallinat J; Garavan H; Gowland P; Heinz A; Lemaitre H; Martinot JL; Nees F; Orfanos DP; Pangelinan MM; Poustka L; Rietschel M; Smolka MN; Walter H; Whelan R; Timpson NJ; Schumann G; Smith GD; Pausova Z; Paus T
JAMA Psychiatry; 2015 Oct; 72(10):1002-11. PubMed ID: 26308966
[TBL] [Abstract][Full Text] [Related]
3. Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences.
Jones HJ; Gage SH; Heron J; Hickman M; Lewis G; Munafò MR; Zammit S
JAMA Psychiatry; 2018 Mar; 75(3):240-246. PubMed ID: 29344610
[TBL] [Abstract][Full Text] [Related]
4. Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence.
Hiemstra M; Nelemans SA; Branje S; van Eijk KR; Hottenga JJ; Vinkers CH; van Lier P; Meeus W; Boks MP
Drug Alcohol Depend; 2018 Sep; 190():143-150. PubMed ID: 30031300
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population.
Jones HJ; Stergiakouli E; Tansey KE; Hubbard L; Heron J; Cannon M; Holmans P; Lewis G; Linden DE; Jones PB; Davey Smith G; O'Donovan MC; Owen MJ; Walters JT; Zammit S
JAMA Psychiatry; 2016 Mar; 73(3):221-8. PubMed ID: 26818099
[TBL] [Abstract][Full Text] [Related]
6. Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories.
Riglin L; Hammerton G; Heron J; Collishaw S; Arseneault L; Thapar AK; Maughan B; O'Donovan MC; Thapar A
Am J Psychiatry; 2019 Jan; 176(1):36-43. PubMed ID: 30486671
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users.
Johnson EC; Colbert SMC; Jeffries PW; Tillman R; Bigdeli TB; Karcher NR; Chan G; Kuperman S; Meyers JL; Nurnberger JI; Plawecki MH; Degenhardt L; Martin NG; Kamarajan C; Schuckit MA; Murray RM; Dick DM; Edenberg HJ; D'Souza DC; Di Forti M; Porjesz B; Nelson EC; Agrawal A
Schizophr Bull; 2023 May; 49(3):778-787. PubMed ID: 36545904
[TBL] [Abstract][Full Text] [Related]
8. Short communication: Genetic association between schizophrenia and cannabis use.
Verweij KJ; Abdellaoui A; Nivard MG; Sainz Cort A; Ligthart L; Draisma HH; Minică CC; ; Gillespie NA; Willemsen G; Hottenga JJ; Boomsma DI; Vink JM
Drug Alcohol Depend; 2017 Feb; 171():117-121. PubMed ID: 28086176
[TBL] [Abstract][Full Text] [Related]
9. Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study.
Martin J; Tilling K; Hubbard L; Stergiakouli E; Thapar A; Davey Smith G; O'Donovan MC; Zammit S
Am J Epidemiol; 2016 Jun; 183(12):1149-58. PubMed ID: 27188935
[TBL] [Abstract][Full Text] [Related]
10. Testing the association between tobacco and cannabis use and cognitive functioning: Findings from an observational and Mendelian randomization study.
Mahedy L; Wootton R; Suddell S; Skirrow C; Field M; Heron J; Hickman M; Munafò MR
Drug Alcohol Depend; 2021 Apr; 221():108591. PubMed ID: 33618197
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression.
Rice F; Riglin L; Thapar AK; Heron J; Anney R; O'Donovan MC; Thapar A
JAMA Psychiatry; 2019 Mar; 76(3):306-313. PubMed ID: 30326013
[TBL] [Abstract][Full Text] [Related]
12. Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample.
Miller AP; Gizer IR; Fleming Iii WA; Otto JM; Deak JD; Martins JS; Bartholow BD
Psychiatry Res; 2019 Sep; 279():47-54. PubMed ID: 31299563
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia polygenic risk is associated with child mental health problems through early childhood adversity: evidence for a gene-environment correlation.
Bolhuis K; Steenkamp LR; Blanken LME; Neumann A; Jansen PR; Hillegers MHJ; Cecil CAM; Tiemeier H; Kushner SA
Eur Child Adolesc Psychiatry; 2022 Mar; 31(3):529-539. PubMed ID: 33635441
[TBL] [Abstract][Full Text] [Related]
14. The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses.
Lubke GH; Stephens SH; Lessem JM; Hewitt JK; Ehringer MA
Behav Genet; 2012 Jul; 42(4):636-46. PubMed ID: 22382757
[TBL] [Abstract][Full Text] [Related]
15. Identifying risk factors involved in the common versus specific liabilities to substance use: A genetically informed approach.
Iob E; Schoeler T; Cecil CM; Walton E; McQuillin A; Pingault JB
Addict Biol; 2021 May; 26(3):e12944. PubMed ID: 32705754
[TBL] [Abstract][Full Text] [Related]
16. Genetic liability to schizophrenia is associated with exposure to traumatic events in childhood.
Sallis HM; Croft J; Havdahl A; Jones HJ; Dunn EC; Davey Smith G; Zammit S; Munafò MR
Psychol Med; 2021 Aug; 51(11):1814-1821. PubMed ID: 32234096
[TBL] [Abstract][Full Text] [Related]
17. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis.
Agerbo E; Sullivan PF; Vilhjálmsson BJ; Pedersen CB; Mors O; Børglum AD; Hougaard DM; Hollegaard MV; Meier S; Mattheisen M; Ripke S; Wray NR; Mortensen PB
JAMA Psychiatry; 2015 Jul; 72(7):635-41. PubMed ID: 25830477
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.
Toulopoulou T; Zhang X; Cherny S; Dickinson D; Berman KF; Straub RE; Sham P; Weinberger DR
Brain; 2019 Feb; 142(2):471-485. PubMed ID: 30535067
[TBL] [Abstract][Full Text] [Related]
19. Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia.
Pries LK; van Os J; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Lin BD; van Eijk KR; Kenis G; Richards A; O'Donovan MC; Luykx JJ; Rutten BPF; Guloksuz S
JAMA Psychiatry; 2020 Dec; 77(12):1296-1304. PubMed ID: 32805017
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk for schizophrenia, disordered eating behaviours and body mass index in adolescents.
Solmi F; Mascarell MC; Zammit S; Kirkbride JB; Lewis G
Br J Psychiatry; 2019 Jul; 215(1):428-433. PubMed ID: 30837007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
